Cindy Lee
CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: A refined target for radiotherapy trials?: Correspondence
Lee, Cindy; Guinn, Barbara Ann; Brooks, Suzanne E.; Richardson, Deborah; Orchard, Kim
Authors
Dr Barbara Guinn B.Guinn@hull.ac.uk
Reader in Biomedical Sciences
Suzanne E. Brooks
Deborah Richardson
Kim Orchard
Citation
Lee, C., Guinn, B. A., Brooks, S. E., Richardson, D., & Orchard, K. (2010). CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: A refined target for radiotherapy trials?: Correspondence. British journal of haematology, 149(5), 795-796. https://doi.org/10.1111/j.1365-2141.2010.08100.x
| Journal Article Type | Letter |
|---|---|
| Online Publication Date | Mar 8, 2010 |
| Publication Date | Jun 1, 2010 |
| Deposit Date | Apr 4, 2022 |
| Journal | British Journal of Haematology |
| Print ISSN | 0007-1048 |
| Publisher | Wiley |
| Peer Reviewed | Peer Reviewed |
| Volume | 149 |
| Issue | 5 |
| Pages | 795-796 |
| DOI | https://doi.org/10.1111/j.1365-2141.2010.08100.x |
| Keywords | CD66; Multiple myeloma; Plasma cells; Targeted radiotherapy |
| Public URL | https://hull-repository.worktribe.com/output/3586994 |
You might also like
Immunotherapeutic Potential of Mutated NPM1 for the Treatment of Acute Myeloid Leukemia
(2024)
Journal Article
Can tumour antigens act as biomarkers for the early detection of non-small cell lung cancer?
(2024)
Journal Article